SIX Swiss Exchange

UBS Advisor David Schachter Named to Forbes/SHOOK Best-in-State Wealth Advisors List 2022

Retrieved on: 
Tuesday, April 26, 2022
General Sports, Sports, Finance, Consulting, Banking, General Entertainment, Professional Services, Entertainment, UBS, New, Baird (investment bank), Athlete, Forbes, Endurance, SIX Swiss Exchange, Investment banking, Solution, NYSE, Sport, Asset management, AEC, Financial services, Film, Interior design, Financial adviser

UBS Wealth Management USA announced today that David Schachter, a Financial Advisor in the firms West Los Angeles Market, has been named to the Forbes/SHOOK Research Best-in-State Wealth Advisors list for 2022.

Key Points: 
  • UBS Wealth Management USA announced today that David Schachter, a Financial Advisor in the firms West Los Angeles Market, has been named to the Forbes/SHOOK Research Best-in-State Wealth Advisors list for 2022.
  • Its wonderful to see David recognized as a Best-in-State Wealth Advisor for a second consecutive year," said Jaron Singletary, West Los Angeles Market Head at UBS Wealth Management USA.
  • This years Forbes/SHOOK Research Best-in-State Wealth Advisors list is comprised of over 6,500 advisors across the country, managing more than $10 trillion in client assets.
  • As the world's largest wealth manager, UBS Global Wealth Management provides comprehensive advice, solutions and services to wealthy families and individuals around the world.

WISeKey Announces the Sale of its 51% Stake in ARAGO for EUR 25.5 Million

Retrieved on: 
Monday, April 25, 2022
Transfer, Knowledge, Computer, The Annual Report, SIX Swiss Exchange, NFT, Adoption, Internet, Automation, NASDAQ, Annual report, WKEY, Transfer agreement, Sale, SIX, Financial assistance (share purchase), Growth, HIRO, EUR, Arago, Technology, Gesellschaft mit beschränkter Haftung, Company, Trust anchor, Artificial intelligence, WIHN, Solution, AI, Big data, Algorithm, Investment, Semiconductor, Fulcrum, IOT, City, Certification, Partnership, Acquisition, HRB, Medical device, Cryptocurrency, Risk management, Blockchain, Computer security

In August 2020, WISeKey and arago started a combined journey to conquer the application of AI in the IoT space.

Key Points: 
  • In August 2020, WISeKey and arago started a combined journey to conquer the application of AI in the IoT space.
  • WISeKey is selling its 51% stake in arago back to a German consortium of investors led by aragos founder through his investment company, OGARA GmbH, for EUR 25.5 million, which is over 5 times the initial investment made by WISeKey to acquire its 51% stake.
  • Since its acquisition, WISeKey has made significant investments to explore the integration of arago AI with WISeKey's Trust and IoT applications.
  • When taking into account these investments, the net cash proceeds from the sale to WISeKey is EUR 17 million.

Infracore SA: Company specialized in healthcare infrastructure in Switzerland - Annual Report 2021

Retrieved on: 
Monday, April 25, 2022
Board, Ageing, Health, Public sector, MPT, CHF, EBIT, Medical Properties Trust, EBITDA, State, Hospital, Technology, Board of directors, WAULT, Company, Rothrist, US, SIX Swiss Exchange, Bed, Director, Investment, MPW, SA, Genolier Swiss Medical Network SA, Pharmaceutical industry, Real estate

With a net profit of CHF 43.5 million (2020: CHF 34.0m), Infracore will distribute an increased dividend of CHF 3.15 per share/non-voting equity share.

Key Points: 
  • With a net profit of CHF 43.5 million (2020: CHF 34.0m), Infracore will distribute an increased dividend of CHF 3.15 per share/non-voting equity share.
  • As at 31 December 2021, the portfolio was valued at CHF 1.2 billion, generating revaluation gains of CHF 6.5 million (2020: CHF 1.7 million).
  • Infracore will pursue its growth strategy in Switzerland, both in the private and in the public sector (through public-private partnerships).
  • The Annuel Report 2021 can be downloaded with the following link:
    Infracore SA is a company dedicated to hospital and health infrastructures.

ObsEva Announces Confirmation of Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids

Retrieved on: 
Monday, April 25, 2022
EMA, Hormone, Nasdaq, Pain, Uterine fibroid, Osteoporosis, Woman, Menopause, Security (finance), NASDAQ, Risk, Patient, PDUFA, Review, Royal commission, UF, U.S. Securities and Exchange Commission, European Commission, Central Research Laboratories, Urology, FDA, Health, Investor, Drug development, Food, Private Securities Litigation Reform Act, Syneos Health, CCO, Theramex, Linzagolix, Endometriosis, Pregnancy, Company, Solution, Contract research organization, Food and Drug Administration, Committee, CEO, European Medicines Agency, Birth certificate, SIX Swiss Exchange, CRO, SEC, Coronavirus, New Drug Application, CHMP, Gonadotropin-releasing hormone, Gynaecology, Clinical trial, EC, Birth, Fertility, Pharmaceutical industry, Kissei

The positive CHMP opinion, which was initially adopted on December 16, 2021, was confirmed at the April 2022 CHMP meeting following further review of the linzagolix marketing authorization application.

Key Points: 
  • The positive CHMP opinion, which was initially adopted on December 16, 2021, was confirmed at the April 2022 CHMP meeting following further review of the linzagolix marketing authorization application.
  • European Commission decisions are valid in the European Union Member States, as well as Iceland, Norway, and Liechtenstein.
  • ObsEva has entered into a licensing agreement with Theramex to support the commercialization and market introduction of linzagolix in Europe.
  • Linzagolix has completed clinical trial development for the treatment of uterine fibroids and is currently in late-stage clinical development for the treatment of pain associated with endometriosis.

Implenia wins large and complex infrastructure project in Norway

Retrieved on: 
Monday, April 25, 2022
Investor relations, CHF, Transport, CEEQUAL, Group, NOK, SIX Swiss Exchange, BIM, Information, Drinking water, Corporate communication, Environment, Solution, Safety, Health, Investor, Civil engineering, Construction, Implenia, Opfikon

Implenia was chosen for this large and complex infrastructure project based on the best score in both quality and price.

Key Points: 
  • Implenia was chosen for this large and complex infrastructure project based on the best score in both quality and price.
  • Both parties have been engaged in extensive dialogue during the competitive tender phase, which supports a smooth implementation of this complex project.
  • Tangenvika railway bridge is a complex and exciting infrastructure project.
  • The project will be CEEQUAL certified," says Christian Spth, Head Division Civil Engineering of Implenia.

Addex to Present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference

Retrieved on: 
Monday, April 25, 2022
Protein, CEO, ADX71149, Nasdaq, Clinical trial, Allosteric regulation, PTSD, PDT, Glutamate (neurotransmitter), Lists of diseases, Psychosis, Dyskinesia, GABAB, Drug discovery, Dystonia, BST, SIX Swiss Exchange, PAM, Conference, Janssen Pharmaceuticals, EDT, Blepharospasm, Glutamate receptor, American depositary receipt, L-DOPA, NAM, Epilepsy, IR, Neurodegeneration, Glutamic acid, Therapy, Pharmaceutical industry

Geneva, Switzerland, April 25, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference taking place April 27 - 28, 2022.

Key Points: 
  • Geneva, Switzerland, April 25, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference taking place April 27 - 28, 2022.
  • A video of each presentation will be available for viewing on-demand by registered participants.
  • Mr Dyer will be available for virtual one-on-one meetings throughout both conferences.
  • For more information or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected] .

Swiss Life shareholders approve all resolutions proposed by the Board of Directors

Retrieved on: 
Saturday, April 23, 2022
Board, Pension, Best Selection (Japan album), Group, Swiss Life, Swiss Life Select, SIX Swiss Exchange, Person, Director, Bank of Ireland, Solution, Life, Nature, Financial adviser

Swiss Life Select, Tecis, Horbach, Proventus, Fincentrum and Chase de Vere advisors choose suitable products for customers from the market according to the Best Select approach.

Key Points: 
  • Swiss Life Select, Tecis, Horbach, Proventus, Fincentrum and Chase de Vere advisors choose suitable products for customers from the market according to the Best Select approach.
  • Swiss Life Asset Managers offers institutional and private investors access to investment and asset management solutions.
  • Swiss Life provides multinational corporations with employee benefits solutions and high net worth individuals with structured life and pensions products.
  • The shares of Swiss Life Holding Ltd are listed on the SIX Swiss Exchange (SLHN).

WISeKey and Porrima.CH Team Up to Launch the First Ever Sustainable NFT Project to Celebrate Earth Day 2022

Retrieved on: 
Friday, April 22, 2022
Computer, Pacific Ocean, CEO, SIX Swiss Exchange, NFT, Internet, Kyoto, Blue economy, Expo 2020, NASDAQ, Research, The Blue Economy, Life, Future, Kyoto Protocol, Science, ART, Creativity, The Big Picture Art Platform, WKEY, Learning, Pregnancy, CH, Egg, Seawater, Entrepreneurship, Non-fungible token, Hydrogen, Technology, Social media, Trust anchor, Environment, Philosophy, Artificial intelligence, WIHN, Foundation, List of Roman deities, EXPO, AI, Big data, Solar energy, History, Semiconductor, Hope, IOT, Wind, City, ZERI, EST, Fulcrum, Renewable energy, Auction, Cryptocurrency, Blockchain, Porrima, Mediterranean Sea, Atlantic Ocean, Metaverse

By July 2022, the solar panels on Porrima - named after the Roman Goddess for the Future - will have navigated 100,000 nautical miles.

Key Points: 
  • By July 2022, the solar panels on Porrima - named after the Roman Goddess for the Future - will have navigated 100,000 nautical miles.
  • Collectors can have as an option to ownboth, the digital NFT plus the correspondent physical item.
  • The first 100 panels are offered for NFT tokenization, which will be announced on April 22, 2022, on Earth Day at 22:00 hrs local time in Tokyo (09:00 am in EST in New York).
  • The WISeKey RoT serves as a common trust anchor to ensure the integrity of online transactions among objects and between objects and people.

OISTE.ORG Foundation Grants its 2022 Sustainability Award to Thinker, Humanist, Scientist, and Aquaculturist Archduke Andrés Salvador Habsburgo-Lorena, Celebrating Earth Day on April 22, 2022

Retrieved on: 
Friday, April 22, 2022
Comité Central de la Comunidad Judía de México, La Sociedad, CPS, SIX Swiss Exchange, Swiss Code of Obligations, Prospectus, Communication, Actualidad Económica, ICANN, ECOSOC, ONG, Sin, Airline, Furniture

Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved.

Key Points: 
  • Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved.
  • http://www.oiste.org/ anuncia hoy durante el Da de la Tierra la nominacin del Archiduque Andrs Salvador Habsburgo-Lorena para el Premio OISTE 2022 a la Sostenibilidad.
  • La sociedad WISeKey acta como el Operador elegido por la fundacin para la gestin de la clave criptogrfica raz.
  • OISTE y WISeKey estn vinculadas por un Marco de Confianza definido y por la Declaracin de Prctica de Certificacin (CPS) .

INSIGHT PARTNERS AND PARTNERS GROUP TO MAKE A STRATEGIC INVESTMENT IN PRECISELY

Retrieved on: 
Thursday, April 21, 2022
Partners Group, CEO, Health, TA Associates, Decision-making, IPO, Willkie Farr & Gallagher, Private equity, Twitter, Rothschild, Software, Insight Partners, Sidley Austin, Leadership, Entrepreneurship, Company, SIX Swiss Exchange, Latham & Watkins, Kirkland & Ellis, LinkedIn, Growth, Investment, Technology, Scale, Insurance, TA, Solution, Evercore, USD, Rothschild & Co, Partnership, Partner (business rank), Bank, Financial services, Insight, BURLINGTON, Centerbridge Partners

BURLINGTON, Mass. and SANTA MONICA, Calif. , April 21, 2022 /PRNewswire/ -- Precisely ("Precisely" or the "Company"), a global leader in data integrity software, today announced that Insight Partners ("Insight") and Partners Group, acting on behalf of its clients, have signed a definitive agreement to make a significant strategic investment in the Company. Insight and Partners Group will join Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake"), TA Associates ("TA"), and Centerbridge Partners ("Centerbridge") as institutional investors in Precisely. Terms of the transaction were not disclosed.

Key Points: 
  • and SANTA MONICA, Calif., April 21, 2022 /PRNewswire/ --Precisely ("Precisely" or the "Company"),a global leader in data integrity software, today announced that Insight Partners ("Insight") and Partners Group, acting on behalf of its clients, have signed a definitive agreement to make a significant strategic investment in the Company.
  • Insight and Partners Group will join Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake"), TA Associates ("TA"), and Centerbridge Partners ("Centerbridge") as institutional investors in Precisely.
  • The additional capital from Insight and Partners Group will enable Precisely to extend its strong market position through continued product innovation and acquisitions.
  • "We welcome our new strategic investment partners, Insight and Partners Group, to help drive continued expansion of the Precisely platform and look forward to supporting Josh and the management team in deploying our O.P.S.